Vilmos Keri

This inventor holds 22 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents, primarily in Pharmaceutical Purification. Top assignees: Biogal Gyogyszergyar Rt., Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag, Teva Gyogyszergyar Reszvenytarsasag. Active years: 1994-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vilmos Keri. Retrieved from https://idiyas.com/inventor/vilmos-keri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22

% Patents Active = 22.7

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 2

Average Co-Inventor Count = 3.6

ph-index = 6

Forward Citations = 83(Granted Patents)

Company Filing History:

8 out of 26

Biogal Gyogyszergyar Rt.

patents

8 out of 26

Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag

patents

2 out of 3

Teva Gyogyszergyar Reszvenytarsasag

patents

4. 1 out of 1

Biogal Gyógyszergyar Rt.

patent

5. 1 out of 1

Biogal Gyogyszerarugyar Rt

patent

6. 1 out of 1

Teva Gyógyszergyár Zártkör{acute Over ())}{Acute Over (})}Úen M{acute Over ())}{Acute Over (})}úköd{acute Over ())}{Acute Over (})}Ó Részvénytársaság

patent

7. 1 out of 1

Teva Gyógyszergyár Zártkörúen Múkó´dó´résvénytársaság

patent

Years Active: 1994-2012

Loading Chart...

Areas of Expertise:

Echinocandin Compounds

Mycophenolic Acid

Crystalline Macrolides

Pravastatin

Lipstatin

Orlistat

Statin Compounds

Cyclosporin A

Deferoxamine

Purification Processes

Fermentation Broth

Crystallization

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8101712 - Purification processes for echinocandin-type compounds (2012-01-24),

2. 7683188 - Process for preparation of mycophenolic acid and ester derivatives thereof (2010-03-23),

3. 7645876 - Processes for producing crystalline macrolides (2010-01-12),

4. 7452692 - Method for extracting a macrolide from biomatter (2008-11-18),

5. 7439252 - Ascomycin crystalline forms and preparation thereof (2008-10-21),

6. 7432074 - Method for extracting a macrolide from biomatter (2008-10-07),

7. 7425644 - Method of purifying pravastatin (2008-09-16),

8. 7262218 - Forms of pravastatin sodium (2007-08-28),

9. 7232486 - Crystallization and purification of macrolides (2007-06-19),

10. 7220357 - Method of purifying macrolides (2007-05-22),

11. 7001919 - Forms of pravastatin sodium (2006-02-21),

12. 6936731 - Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same (2005-08-30),

13. 6858414 - Multistage process for the preparation of highly pure deferoxamine mesylate salt (2005-02-22),

14. 6844174 - Fermentation process for lipstatin and method of extracting lipstatin from a fermentation broth (2005-01-18),

15. 6734314 - Preparation of orlistat and orlistat crystalline forms (2004-05-11),

Certainly! Here is the article about inventor Vilmos Keri:

Title: Unveiling the Innovations of Vilmos Keri from Debrecen, HU

Introduction:

Vilmos Keri, a prominent inventor hailing from Debrecen, Hungary, has made significant contributions to the field of pharmaceuticals with his creative inventions and patents.

Latest Patents:

1. Purification processes for echinocandin-type compounds: Vilmos Keri's innovative method for preparing and purifying echinocandin-type compounds has paved the way for the production of crucial antifungal products such as Caspofungin and Mycafungin.

2. Process for preparation of mycophenolic acid and ester derivatives: His process for the preparation of mycophenolic acid and its ester derivatives has been instrumental in pharmaceutical advancements.

Career Highlights:

With an impressive portfolio of 22 patents, Vilmos Keri has showcased his expertise in the pharmaceutical industry. He has been a key player in companies like Biogal Gyogyszergyar Rt. and Teva Gyógyszergyár Zártkörűen Működő Részvénytársaság.

Collaborations:

Throughout his career, Vilmos Keri has collaborated with esteemed professionals such as Csaba Szabo and Andrea Csorvasi, fostering a culture of innovation and excellence in his work.

Conclusion:

Vilmos Keri's groundbreaking inventions and patents reflect his dedication to advancing the pharmaceutical industry. His contributions have not only enhanced the field of medicine but have also inspired a new generation of inventors to push the boundaries of innovation further.

Profile summary based on public USPTO records.